-
公开(公告)号:US20230004850A1
公开(公告)日:2023-01-05
申请号:US17781389
申请日:2020-12-02
Inventor: Yuval OREG , Gal SHAVIT , Omri LESSER , Erez BERG , Adiel STERN , Karsten FLENSBERG
Abstract: Provided is a quantum computing device comprising a carbon nanotube, a superconducting substrate in quantum proximity to the nanotube and being in a superconducting state having a pairing correlation matrix with a substantial spin-triplet component in a direction perpendicular to the nanotube, and a magnet arranged to provide a longitudinal magnetic field along a longitudinal axis of the nanotube. Further provided is a quantum computing device comprising at least three substrates made of a superconductor material and each in a superconducting state, and a non-superconducting structure made of a material in which the electrons' closed trajectories experience strong spin-orbit coupling interactions and being in quantum proximity to the substrates. The sum of the phase differences between the order parameters of all of the substrates is at least π.
-
公开(公告)号:US20230003742A1
公开(公告)日:2023-01-05
申请号:US17781706
申请日:2020-12-10
Applicant: ICHILOV TECH LTD. , YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Shani Shenhar-Tsarfaty , Shlomo Avraham Berliner , Ori Rogowski , Eyal Fisher , Adi Silberman , Yishai Levin
IPC: G01N33/68
Abstract: The invention provides assays and methods for detecting and monitoring systemic inflammation Particularly, the invention in embodiments thereof relates to the use of urinary biomarkers for non-invasive determination of the level of inflammation.
-
公开(公告)号:US20220372145A1
公开(公告)日:2022-11-24
申请号:US17876641
申请日:2022-07-29
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Ido AMIT , Assaf WEINER , Yonatan KATZENELENBOGEN , Adam YALIN , Fadi SHEBAN
Abstract: A method of reducing the immune suppressor activity of myeloid cells is disclosed. The method comprises contacting myeloid cells with an effective amount of an agent which specifically reduces the amount and/or activity of myeloid cells expressing both Triggering Receptor Expressed On Myeloid Cells 2 (Trem2) and Transmembrane glycoprotein NMB (Gpnmb). The method can be used for treating cancer. Antibodies and bi-specific antibodies are also disclosed.
-
公开(公告)号:US20220370517A1
公开(公告)日:2022-11-24
申请号:US17854034
申请日:2022-06-30
Applicant: Ichilov Tech Ltd. , Yeda Research and Development Co. Ltd.
Inventor: Eran SEGAL , Jacob MASHIAH , Nitsan MAHARSHAK
IPC: A61K35/741 , A61K35/745 , A61K35/742 , A61K35/24 , A61P17/00
Abstract: A method of treating atopic dermatitis (AD) in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of at least two species of bacteria.
-
公开(公告)号:US20220362329A1
公开(公告)日:2022-11-17
申请号:US17875551
申请日:2022-07-28
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Eran ELINAV , Ido AMIT , Aleksandra Anna KOLODZIEJCZYK
IPC: A61K38/14 , A61P1/16 , A61K31/43 , A61K31/7036 , A61K31/4164
Abstract: Methods of treating acute liver disease acute liver diseases are provided. Accordingly, there is provided a method of treating acute liver disease in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an agent capable of binding a component of a TLR-MYC signaling pathway selected from the group consisting of MYC, MYD88, TRIF and p38 and inhibiting expression and/or activity of the component.
-
246.
公开(公告)号:US11492405B2
公开(公告)日:2022-11-08
申请号:US16728642
申请日:2019-12-27
Applicant: Yeda Research and Development Co. Ltd
Inventor: Michal Eisenbach-Schwartz , Kuti Baruch , Neta Rosenzweig
IPC: C07K16/28 , A61K39/395 , A61P25/16 , A61P25/28 , A61K31/4155 , A61K31/7068 , A61K31/404 , A61K33/36 , A61K45/06 , A61P37/06 , A61P27/02 , A61K39/00
Abstract: The present specification discloses a pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS. The pharmaceutical composition is administered by a dosage regimen comprising at least one course of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session of non-treatment.
-
公开(公告)号:US11480568B2
公开(公告)日:2022-10-25
申请号:US16133295
申请日:2018-09-17
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Rachel Sorek , Keren Jakobi-Brook , Pennina Safer , Irun R. Cohen
IPC: G01N33/564 , G01N33/577
Abstract: Assays and methods for diagnosing and treating autoimmune diseases. Particularly, the invention provides methods for differential diagnosis of specific autoimmune diseases, including autoimmune rheumatic disorders.
-
公开(公告)号:US11471430B2
公开(公告)日:2022-10-18
申请号:US17261255
申请日:2019-07-17
Inventor: Anthony H. Futerman , Tammar Joseph , Walter A. Shaw , Stephen W. Burgess , Shengrong Li
IPC: A61K31/167 , A61K31/133 , A61K31/164
Abstract: Provided herein is a group of sphingosine analogs, useful in the treatment of bacterial infections in mucosal surfaces such as lungs, caused by pathogenic bacteria which are typical to disorders and diseases such as CF and COPD.
-
公开(公告)号:US20220265696A1
公开(公告)日:2022-08-25
申请号:US17734199
申请日:2022-05-02
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Alon CHEN , Eran HORNSTEIN , Orna ISSLER , Sharon HARAMATI , Naama VOLK
IPC: A61K31/7105 , A61K31/713 , C12Q1/6883 , C12N15/113 , A61K48/00
Abstract: microRNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions are provided.
-
公开(公告)号:US20220260819A1
公开(公告)日:2022-08-18
申请号:US17624344
申请日:2020-07-02
Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
Inventor: Dan ORON , Uri ROSSMAN , Ron TENNE , Yonina C. ELDAR
IPC: G02B21/00
Abstract: A method of generating an image of a sample is provided. The method comprises providing a plurality of photon detectors, scanning the sample with an excitation beam over a predetermined time period, the detectors receiving photons emitted by the sample due to the excitation during the time period. A plurality of intensity images associated with each of the detectors are generated, each being proportional to the mean number of photons detected per unit time. A plurality of correlation images associated with each combination of two of the detectors are generated, each of the correlation images being proportional to the variance of the distribution of detected photons per unit time. The image of the sample is generated using joint sparse recovery from the plurality of intensity and correlation images, wherein the intensity and correlation images have common support.
-
-
-
-
-
-
-
-
-